Vivek Jain, MD, MAS
Professor
Medicine
School of Medicine

415-476-4082 ext. 355

Vivek Jain, MD, MAS, FIDSA is a Professor of Medicine and Infectious Diseases in the Division of HIV, Infectious Diseases & Global Medicine at San Francisco General Hospital (SFGH) at the University of California, San Francisco (UCSF).

Show full bio (350 words) Hide full bio

Dr. Jain is an infectious disease specialist focused on HIV, general infectious diseases, and internal medicine. He is the director of the SFGH Infectious Diseases Clinic, where he sees outpatients, and directs the clinic home-based antibiotics program. Dr. Jain also serves as an attending physician on the Infectious Diseases Consult Service and serves as an HIV-focused primary care doctor in the Positive Health Practice Clinic of SFGH.

Dr. Jain is also co-director of the SFGH Infection Control and Prevention Team, and oversees clinical operations of the COVID-19 team. Dr. Jain also directs COVID-19 outpatient therapies, including a telemedicine program for COVID-19 patients to access rapid therapy, and an on-campus treatment program. He also conducts research on COVID-19 epidemiology, clinical presentations and outcomes, and implementation science models for optimal COVID-19 therapeutic strategies.

Dr. Jain has also conducted implementation science research on HIV antiretroviral therapy (ART) delivery in resource limited settings, working with collaborators at Makerere University and the Infectious Diseases Research Collaboration (IDRC) in Kampala, Uganda and in Kenya. Research has included studies of early diagnosis and immediate/early treatment of HIV with antiretroviral therapy, and strategies for improving the use of HIV viral load tests and other infectious disease diagnostics for clinics and hospitals. Dr. Jain's research has included the EARLI Study (one of Africa's first studies of ART administration to individuals with high CD4+ T-cell counts), the SEARCH Study (a large cluster randomized trial of wide scale HIV testing and universal HIV ART in 32 communities in Uganda and Kenya), and the RAPID-VL Study (a cluster randomized trial of a novel combination intervention to optimize the way HIV viral load testing is performed in HIV clinics in Uganda).

Dr. Jain is co-director of the Global Infectious Diseases course in the UCSF Global Health Sciences Master's Degree program, and lectures extensively on infectious diseases topics.

Dr. Jain earned his undergraduate degree in Biochemistry from Harvard University, followed by his M.D. from Stanford University School of Medicine. He completed residency, chief residency, and infectious diseases fellowship at UCSF, and an M.A.S. degree in clinical research also at UCSF.

Education & Training

Show all (6) Hide

  • M.A.S. Epidemiology and Biostatistics UCSF 2010
  • Fellowship Infectious Diseases UCSF 2009
  • Chief Residency Internal Medicine UCSF 2007
  • Residency Internal Medicine UCSF 2006
  • M.D. Stanford University School of Medicine 2003
  • A.B. Harvard University 1998

Interests

Show all (15) Hide

  • infectious disease
  • ART delivery
  • HIV antiretroviral therapy (ART)
  • clinical cohorts
  • HIV therapeutic strategies
  • HIV
  • HIV immunology
  • acute/early HIV disease
  • HIV drug resistance
  • resource limited settings
  • clinical trials
  • implementation science
  • HIV virology
  • Sub Saharan Africa
  • early ART

Websites

Show all (3) Hide

Grants and Projects

Show all (2) Hide

  • RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations, CDC, 2016-2020
  • Early Antiretroviral Therapy in Patients with High CD4+ T Cell Counts in Resource Limited Settings (EARLI), Gilead Sciences, 2012-2017

Publications (70)

Top publication keywords:
Viral LoadAnti-HIV AgentsCD4 Lymphocyte CountEndocarditis, BacterialStaphylococcal InfectionsRNA, ViralAnti-Retroviral AgentsRural PopulationUgandaTreatment RefusalKenyaHIV-1Noncommunicable DiseasesBacteremiaHIV Infections

Show all (65 more) Hide